Currently Available for Review

Technology Assessment: Report on the Evidence Regarding Off-Label Indications for Targeted Therapies used in Cancer Treatment (PDF file, 4.2 MB; PDF Help)
Date Available: 9:00 AM October 26 - 5:00 PM November 16.

Note: Due to a delay in the distribution of the review announcement to the TA Program E-mail list, the review period for the technology assessment draft on targeted therapies for cancer will be extended until November 16, 2009.